We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA handed a warning letter to Anigan for numerous GMP violations it uncovered during an April 2018 inspection of the firm’s San Ramon, California facility. Read More
The FDA faulted the Siemens facility for not properly verifying the accuracy of the reagent expiration dates its software calculated and generated. Read More
The device acts like an invisible scalpel, delivering small thermal ablations beneath the skin to soft tissue to promote collagen growth and regenerate connective tissue. Read More
It has been used in situations where antidepressant treatments are ineffective and before invasive therapies — such as electroconvulsive therapy — are considered. Read More